These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9159699)

  • 21. Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example.
    Elkin EB; Cowen ME; Cahill D; Steffel M; Kattan MW
    Med Decis Making; 2004; 24(5):504-10. PubMed ID: 15358999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A critique of the decision analysis for clinically localized prostate cancer.
    Beck JR; Kattan MW; Miles BJ
    J Urol; 1994 Nov; 152(5 Pt 2):1894-9. PubMed ID: 7933246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
    Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
    Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy.
    Breeuwsma AJ; Rybalov M; Leliveld AM; Pruim J; de Jong IJ
    Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):440-6. PubMed ID: 23069923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A decision support model for cost-effectiveness of radical prostatectomy in localized prostate cancer.
    Lyth J; Andersson SO; Andrén O; Johansson JE; Carlsson P; Shahsavar N
    Scand J Urol Nephrol; 2012 Feb; 46(1):19-25. PubMed ID: 21905981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.
    Harlan LC; Potosky A; Gilliland FD; Hoffman R; Albertsen PC; Hamilton AS; Eley JW; Stanford JL; Stephenson RA
    J Natl Cancer Inst; 2001 Dec; 93(24):1864-71. PubMed ID: 11752011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early outcomes of active surveillance for localized prostate cancer.
    Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
    BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
    Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K
    Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
    Walz J; Gallina A; Perrotte P; Jeldres C; Trinh QD; Hutterer GC; Traumann M; Ramirez A; Shariat SF; McCormack M; Perreault JP; Bénard F; Valiquette L; Saad F; Karakiewicz PI
    BJU Int; 2007 Dec; 100(6):1254-8. PubMed ID: 17979925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical prostatectomy versus watchful waiting in early prostate cancer.
    Bill-Axelson A; Holmberg L; Ruutu M; Häggman M; Andersson SO; Bratell S; Spångberg A; Busch C; Nordling S; Garmo H; Palmgren J; Adami HO; Norlén BJ; Johansson JE;
    N Engl J Med; 2005 May; 352(19):1977-84. PubMed ID: 15888698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [How to treat a localized prostate cancer: irradiation, surgery or watchful waiting?].
    Zellweger T; Gasser T
    Praxis (Bern 1994); 2005 Aug; 94(34):1307-8. PubMed ID: 16170999
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
    JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
    Culp SH; Schellhammer PF; Williams MB
    Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active surveillance versus surgery for low risk prostate cancer: a clinical decision analysis.
    Liu D; Lehmann HP; Frick KD; Carter HB
    J Urol; 2012 Apr; 187(4):1241-6. PubMed ID: 22335873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recursive partitioning for prognostic grouping of patients with clinically localized prostate carcinoma.
    Banerjee M; Biswas D; Sakr W; Wood DP
    Cancer; 2000 Jul; 89(2):404-11. PubMed ID: 10918173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer screening: a decision analysis.
    Cantor SB; Spann SJ; Volk RJ; Cardenas MP; Warren MM
    J Fam Pract; 1995 Jul; 41(1):33-41. PubMed ID: 7798064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate biopsy: who, how and when. An update.
    Djavan B; Milani S; Remzi M
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.